Tell us about your organization

 
 

Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Business Information

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

PeraHealth

Headquarters:

Charlotte North Carolina, United States

Sector Funding:

Go to Website

PeraHealth's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

The Rothman Index platform COVID-19 update
Capacity management specifically aimed at helping health systems address the anticipated influx of patients

PeraHealth has launched a new capacity management feature specifically aimed at helping health systems address the anticipated influx of patients from the COVID-19 pandemic. This enhancement to The Rothman Index platform incorporates the clinical criteria relevant to COVID-19 and will help hospitals safely and efficiently identify patients as candidates for discharge, and that will improve patient flow and allow hospitals to admit and treat more patients.

This new product enhancement is built on the Rothman Index platform, which includes a suite of FDA-cleared, clinically validated tools for use across the patient surveillance ecosystem. Powered by machine learning, the Rothman Index uses patient vitals, labs, and clinical assessments in the EMR to drive actionable insights toward patient care.

The new enhancement supports seamless access within the EMR, optimizing ease of use by clinicians while providing an on-demand, real-time graphical view of patients meeting criteria for discharge consideration. The system allows both preconfigured as well as customized criteria, providing valuable flexibility for use with different diagnoses and service lines. It is adaptable to align with changing operational realities within the hospital. The tool permits discharge filter criteria to use not only Rothman Index-based criteria but also a wide range of other clinically relevant measures for COVID-19.

Using the qualified short list of patients tagged for discharge consideration enables caregivers and case managers to engage quickly in the clinical conversation of, “Is there a reason not to discharge this patient?” They can also discuss the patient’s potential transition to a lower level of care or an at-home quarantine protocol.

Rothman Index solutions are renowned for being research driven and evidence based, and PeraHealth’s latest offering is no different by being created in consultation with expert nurses and physicians and underpinned by analysis of over 100,000 patient discharges from multiple hospitals around the United States.

PeraHealth’s goal is to help hospitals quickly identify acute care patients that are candidates for discharge, freeing much needed hospital bed capacity in the ongoing fight against COVID-19. The new capacity management feature is being made available to all current Rothman Index customers and is an option for any organization wishing to implement Rothman Index solutions.


Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Software Overall Score Data collected between Jan 2020 - Jan 2021


 Product
Segment
 

Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

# of Unique Organization Evaluations:

0 - 5
L 6 - 14

Segment Position

Segment positions refer to the order in which this product is scored among competitors’ products within its market segment.

In order to be scored in a segment, the product must have sufficient data levels and be equivalent in scope to other products within that segment.

Click the segment positions listed below to learn more.